Skip to main content

and
  1. Article

    Open Access

    Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum

    Alzheimer’s disease (AD) cerebrospinal fluid (CSF) core biomarkers (Aβ42/40 ratio, p-tau, and t-tau) provide high diagnostic accuracy, even at the earliest stage of disease. However, these markers do not fully...

    Silvia Paciotti, Anna Lidia Wojdała, Giovanni Bellomo in Alzheimer's Research & Therapy (2023)

  2. Article

    Open Access

    Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women

    A non-invasive endometrial cancer detection tool that can accurately triage symptomatic women for definitive testing would improve patient care. Urine is an attractive biofluid for cancer detection due to its ...

    Kelechi Njoku, Andrew Pierce, Bethany Geary, Amy E. Campbell in British Journal of Cancer (2023)

  3. Article

    Open Access

    Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays

    Aggregation of α-synuclein (α-syn) is a prominent feature of Parkinson’s disease (PD) and other synucleinopathies. Currently, α-syn seed amplification assays (SAAs) using cerebrospinal fluid (CSF) represent th...

    Giovanni Bellomo, Silvia Paciotti, Luis Concha-Marambio in Molecular Neurodegeneration (2023)

  4. Article

    Open Access

    Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies

    Cancer has no borders: Generation and analysis of molecular data across multiple centers worldwide is necessary to gain statistically significant clinical insights for the benefit of patients. Here we conceive...

    Yue Xuan, Nicholas W. Bateman, Sebastien Gallien, Sandra Goetze in Nature Communications (2020)

  5. Article

    Open Access

    Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?

    Cerebrospinal fluid (CSF) amyloid-beta (Aβ) 42/40 ratio, threonine-181-phosphorylated-tau (p-tau), and total-tau (t-tau) represent core biomarkers of Alzheimer disease (AD). The recent availability of automate...

    Giovanni Bellomo, Samuela Cataldi, Silvia Paciotti in Alzheimer's Research & Therapy (2020)

  6. Article

    Open Access

    Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies

    Mutations in the GBA gene, encoding the lysosomal hydrolase glucocerebrosidase (GCase), are the most common known genetic risk factor for Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). The present ...

    Tim E. Moors, Silvia Paciotti, Angela Ingrassia in Molecular Neurobiology (2019)

  7. Article

    Open Access

    Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

    Neurodegenerative disorders such as Alzheimer’s disease (AD), Parkinson’s disease with dementia (PDD), and dementia with Lewy bodies (DLB) share clinical and molecular features. Cerebrospinal fluid (CSF) bioma...

    Davide Chiasserini, Leonardo Biscetti, Paolo Eusebi in Alzheimer's Research & Therapy (2017)

  8. Article

    Open Access

    Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease

    Several studies reported an association between CSF alpha-synuclein (α-syn) and tau in Alzheimer’s disease (AD), and demonstrated the significance of α-syn in improving the diagnostic sensitivity/specificity o...

    Nour K. Majbour, Davide Chiasserini, Nishant N. Vaikath, Paolo Eusebi in Scientific Reports (2017)

  9. Article

    Open Access

    No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF

    Cerebrospinal fluid (CSF) biomarkers have gained increasing importance in the diagnostic work-up of Alzheimer’s disease (AD). The core CSF biomarkers related to AD pathology (Aβ42, t-tau and p-tau) are current...

    Claudia Cicognola, Davide Chiasserini, Paolo Eusebi in Molecular Neurodegeneration (2016)

  10. Article

    Open Access

    Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis

    Scientific Reports 6: Article number: 20926; published online: 18 February 2016; updated: 13 April 2016 The original version of this Article contained an error in the title of the paper, where “Persistent acti...

    Massimiliano Di Filippo, Antonio de Iure, Carmela Giampà in Scientific Reports (2016)

  11. Article

    Open Access

    Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis

    Cognitive impairment is common in multiple sclerosis (MS). Unfortunately, the synaptic and molecular mechanisms underlying MS-associated cognitive dysfunction are largely unknown. We explored the presence and ...

    Massimiliano Di Filippo, Antonio de Iure, Carmela Giampà in Scientific Reports (2016)

  12. No Access

    Article

    Identification and Partial Characterization of Two Populations of Prostasomes by a Combination of Dynamic Light Scattering and Proteomic Analysis

    Prostasomes are vesicles secreted by prostate epithelial cells and are found in abundance in the semen. Here we characterized two different prostasome populations isolated from human seminal fluid. Prostasomes...

    Davide Chiasserini, Michela Mazzoni, Federico Bordi in The Journal of Membrane Biology (2015)

  13. Article

    Open Access

    Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies

    Lysosomal dysfunction is thought to be a prominent feature in the pathogenetic events leading to Parkinson’s disease (PD). This view is supported by the evidence that mutations in GBA gene, coding the lysosomal h...

    Davide Chiasserini, Silvia Paciotti, Paolo Eusebi in Molecular Neurodegeneration (2015)

  14. No Access

    Article

    Cerebrospinal fluid biomarkers in Parkinson disease

    Parkinson disease (PD) begins with a long preclinical phase, which represents both a diagnostic challenge and a potential therapeutic opportunity for early intervention. Parnetti and colleagues discuss growing...

    Lucilla Parnetti, Anna Castrioto, Davide Chiasserini in Nature Reviews Neurology (2013)